Search results for "DIABETES MELLITUS"

showing 10 items of 2077 documents

Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: Studies in hepatic and non-hepatic diseas…

1975

In chronic active hepatitis (CAH, n=58) 70% of the HBsAg negative and 48% of the HBsAg positive cases showed a CMI against human liver specific proteins (HLPI). Using HBsAg as antigen only 12% of the HBsAg negative and 24% of the HBsAg positive cases gave a CMI response. On the basis of HBsAg and autoantibodies in the serum CAH patients could be divided into 4 subgroups. A close correlation between CMI against HLPI, sex, ANA and HL-A-8 could be detected. In a follow-up study of patients with acute virus B hepatitis (n=62) CMI against HBsAg was detected in 60% of the cases in the acute phase of the disease but in 15% only 3-6 months after the onset of the illness (n=40). In patients who deve…

HBsAgTuberculinBiologyAntibodiesVirusHepatitisAntigen-Antibody ReactionsHepatitis B AntigensSex FactorsAntigenAntibody SpecificityImmunityNeoplasmsDrug DiscoveryDiabetes MellitusLeukocytesmedicineHumansTuberculosisGenetics (clinical)AutoantibodiesHepatitisImmunity CellularLiver DiseasesAutoantibodyMuscle SmoothGeneral MedicineHepatitis Amedicine.diseaseVirus DiseasesAntibodies AntinuclearCell Migration InhibitionChronic DiseaseImmunologyMolecular MedicineOrgan SpecificityKlinische Wochenschrift
researchProduct

Ajūrvēda individualizētā cukura diabēta terapijā

2015

Definējot iekļaušanas un izslēgšanas kritērijus, tika veikts randomizēts divu grupu, placebo un kontroles grupas, prospektīvs pētījums, kurā tika iekļauti 32 pacienti. Pirmās pētījuma grupas pacienti lietoja Ajūrvēdas medikamentus kombinācijā ar konvencionālu ārstēšanu un otrās grupas pacienti lietoja placebo medikamentus kombinācijā ar konvencionālu ārstēšanu. Nepieciešami precīzāki iekļaušanas kritēriji, lai veiktu stratificētu nejaušās izlases pētījumu gan Prakriti, gan Vikriti apakšgrupās. Tas nodrošinātu adekvātu pacientu skaitu abās apakšgrupās, pirms statistiskās analīzes veikšanas. Tika pamatota korelācija starp ĶMI/aptaukošanos un 2.tipa cukura diabētu. Trīs mēnešu laikā glikoze tu…

Hba1cDiabetes MellitusAyurvedaFasting Blood GlucoseMedicīnaBody Mass Index
researchProduct

Treatment of diabetes and heart failure: Facts and hopes.

2022

Heart FailureHopepreventionDiabetes MellitusHumansCardiology and Cardiovascular MedicineInternational journal of cardiology
researchProduct

2018

Heme oxygenasebusiness.industryDiabetes mellitusmedicinePharmacologymedicine.diseasebusinessJournal of Cardiology & Cardiovascular Therapy
researchProduct

Association between C′3 phenotypes and various diseases

1972

The distribution of C′3 phenotypes in leprosy, rheumatism, diabetes, hyperlipedemia and hepatitis were studied. There was a significant excess of FF-phenotypes in patients with rheumatic factor while in hepatitis the SS-phenotype was significantly lower and a relatively high frequency of FF was stated. The results are discussed.

Hepatitisbusiness.industrymedicine.diseasePhenotypeSex chromatinDiabetes mellitusImmunologyGeneticsmedicineIn patientLeprosyMetabolic diseasebusinessGenetics (clinical)RheumatismHuman Genetics
researchProduct

Silver-Russell syndrome associated to Mayer-Rokitansky-Kuster-Hauser syndrome, diabetes and hirsutism

2001

We report an unusual association of two rare conditions, the Silver-Russell syndrome and the Mayer-Rokitansky-Küster-Hauser syndrome, with extra endocrine anomalies. A 15-year old Silver-Russell syndrome girl was referred to our Unit because of primary amenorrhea and hirsutism of adrenal origin. A thorough assessment confirmed previous diagnoses and revealed the presence of diabetes, hyperinsulinism and a complete Mayer-Rokitansky-Küster-Hauser syndrome with an ectopic localization of both ovaries. Although initial medical treatment was not unsatisfactory, future medical, psychological and social implications are expected.

Hirsutismmedicine.medical_specialtyAdolescentmedia_common.quotation_subjectDiagnosis DifferentialDiabetes mellitusDiabetes MellitusmedicineHumansEndocrine systemMayer-Rokitansky-Kuster-Hauser SyndromeGirlAmenorrheahirsutismmedia_commonGynecologyMedical treatmentbusiness.industrySilver–Russell syndromeUterusObstetrics and GynecologySyndromeGeneral Medicinemedicine.diseaseDermatologyKaryotypingVaginaFemalebusinessHyperinsulinismArchives of Gynecology and Obstetrics
researchProduct

Enlarged PLIN5-uncoated lipid droplets in inner regions of skeletal muscle type II fibers associate with type 2 diabetes

2022

Skeletal muscle physiology remains of paramount importance in understanding insulin resistance. Due to its high lipid turnover rates, regulation of intramyocellular lipid droplets (LDs) is a key factor. Perilipin 5 (PLIN5) is one of the most critical agents in such regulation, being often referred as a protector against lipotoxicity and consequent skeletal muscle insulin resistance. We examined area fraction, size, subcellular localization and PLIN5 association of LDs in two fiber types of type 2 diabetic (T2D), obese (OB) and healthy (HC) individuals by means of fluorescence microscopy and image analysis. We found that T2D type II fibers have a significant sub-population of large and inter…

Histologylipid dropletsMuscle Fibers SkeletalSkeletal musclelihaksetlipiditPerilipin-5Type II diabetesSDG 3 - Good Health and Well-beinginsulin resistanceHumansskeletal muscleMuscle SkeletalInsulin resistanceCell BiologyGeneral MedicineLipid MetabolismLipid dropletsinsuliiniresistenssifiber typePLIN5Diabetes Mellitus Type 2/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingproteiinitFiber typeaikuistyypin diabetes
researchProduct

Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registr…

2022

Abstract Aims Type 2 diabetes (T2DM) in patients with coronavirus disease-19 (COVID-19) is associated with a worse prognosis. We separately investigated the associations between the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1 RA), and dipeptidyl peptidase-4 inhibitors (DPP-4i), and the risk of COVID-19 hospitalization and death. Methods and results Patients with T2DM registered in the Swedish National Patient Registry and alive on 1 February 2020 were included. ‘Incident severe COVID-19’ was defined as the first hospitalization and/or death from COVID-19. A modified Poisson regression approach was applied to a 1:1 propensity sc…

HospitalizationDipeptidyl-Peptidase IV InhibitorsGlucoseDiabetes Mellitus Type 2Glucagon-Like Peptide 1COVID-19 Dipeptidyl peptidase-4 inhibitors (DPP-4i) Glucagon-like peptide-1 receptor agonists Hospitalization Mortality Sodium-glucose cotransporter 2 inhibitorsHumansCOVID-19Pharmacology (medical)RegistriesCardiology and Cardiovascular MedicineGlucagon-Like Peptide-1 Receptor
researchProduct

Impact of probiotics on risk factors for cardiovascular diseases. A review.

2014

International audience; Probiotic microorganisms have historically been used to rebalance disturbed intestinal microbiota and to diminish gastrointestinal disorders, such as diarrhea or inflammatory bowel diseases (e.g., Crohn's disease and ulcerative colitis). Recent studies explore the potential for expanded uses of probiotics on medical disorders that increase the risk of developing cardiovascular diseases and diabetes, such as obesity, hypercholesterolemia, arterial hypertension, and metabolic disturbances such as hyperhomocysteinemia and oxidative stress. This review aims at summarizing the proposed molecular and cellular mechanisms involved in probiotic-host interactions and to identi…

HypercholesterolemiaHyperhomocysteinemiaDiseaseBiologyIndustrial and Manufacturing Engineeringlaw.invention03 medical and health sciencesProbioticImmune systemRisk Factors[ CHIM.ORGA ] Chemical Sciences/Organic chemistrylawImmunityDiabetes mellitusDiabetes MellitusmedicineAnimalsHumansObesity030304 developmental biology0303 health sciences030306 microbiology[CHIM.ORGA]Chemical Sciences/Organic chemistryMicrobiotaProbioticsImmunityGeneral MedicineLipid Metabolismmedicine.diseaseObesityUlcerative colitisEnzymes3. Good healthIntestinesOxidative StressDiarrheaCardiovascular DiseasesHypertensionImmunologymedicine.symptomFood Science
researchProduct

Sodium zirconium cyclosilicate: a new potassium binder for the treatment of hyperkalemia

2018

Hyperkalemia is one of the most common electrolyte disturbances, especially among some groups of patients, such as in those with chronic kidney disease, diabetes or heart failure. Hyperkalemia has been associated with increased risks of mortality, arrhythmias, hospitalization and costs, as well as the need to down titrate/discontinue renin-angiotensin-aldosterone system inhibitors (RAASIs), despite their well-known cardiovascular and nephroprotective benefits. Current potassium binders have limitations (slow onset of action, limited selectivity for potassium binding, risk of drug interactions or gastrointestinal intolerance). Sodium zirconium cyclosilicate (SZC) is a new potassium binder re…

Hyperkalemiabusiness.industrySilicatesPotassiumchemistry.chemical_elementPharmacologymedicine.diseaseRenin-Angiotensin Systemchemistry.chemical_compoundchemistryTolerabilityHeart failureDiabetes mellitusPotassiumHumansHyperkalemiaPotassium binderMedicineOnset of actionmedicine.symptombusinessKidney diseaseDrugs of Today
researchProduct